Biofil Chemicals & Pharmaceuticals Limited (BIOFILCHEM) - Total Assets
Based on the latest financial reports, Biofil Chemicals & Pharmaceuticals Limited (BIOFILCHEM) holds total assets worth Rs553.64 Million INR (≈ $5.99 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore BIOFILCHEM operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Biofil Chemicals & Pharmaceuticals Limited - Total Assets Trend (2008–2025)
This chart illustrates how Biofil Chemicals & Pharmaceuticals Limited's total assets have evolved over time, based on quarterly financial data. See Biofil Chemicals & Pharmaceuticals Limit shareholders equity for net asset value and shareholders' equity analysis.
Biofil Chemicals & Pharmaceuticals Limited - Asset Composition Analysis
Current Asset Composition (March 2025)
Biofil Chemicals & Pharmaceuticals Limited's total assets of Rs553.64 Million consist of 83.5% current assets and 16.5% non-current assets.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs1.32 Million | 0.3% |
| Accounts Receivable | Rs383.15 Million | 75.2% |
| Inventory | Rs33.41 Million | 6.6% |
| Property, Plant & Equipment | Rs83.45 Million | 16.4% |
| Intangible Assets | Rs0.00 | 0.0% |
| Goodwill | Rs0.00 | 0.0% |
Asset Composition Trend (2008–2025)
This chart illustrates how Biofil Chemicals & Pharmaceuticals Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see how much is Biofil Chemicals & Pharmaceuticals Limit worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Biofil Chemicals & Pharmaceuticals Limited's current assets represent 83.5% of total assets in 2025, an increase from 10.2% in 2008.
- Cash Position: Cash and equivalents constituted 0.3% of total assets in 2025, down from 0.8% in 2008.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2008.
- Asset Diversification: The largest asset category is accounts receivable at 75.2% of total assets.
Biofil Chemicals & Pharmaceuticals Limited Competitors by Total Assets
Key competitors of Biofil Chemicals & Pharmaceuticals Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Takeda Pharmaceutical Company Limited
F:TKDA
|
Germany | €15.41 Trillion |
|
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858
|
China | CN¥19.57 Billion |
|
Beijing Sun Novo Pharmaceutical Research Co Ltd
SHG:688621
|
China | CN¥2.30 Billion |
|
Guizhou Xinbang Pharmaceutical Co Ltd
SHE:002390
|
China | CN¥8.59 Billion |
|
Guangdong Lifestrong Pharmacy Co. Ltd.
SHE:301111
|
China | CN¥925.41 Million |
|
Jw Pharmac
KO:001060
|
Korea | ₩605.27 Billion |
|
Kamada
TA:KMDA
|
Israel | ILA377.21 Million |
|
Samjin Pharm
KO:005500
|
Korea | ₩449.14 Billion |
Biofil Chemicals & Pharmaceuticals Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.44 | 1.44 | 1.33 |
| Quick Ratio | 1.33 | 1.15 | 1.27 |
| Cash Ratio | 0.01 | 0.01 | 0.00 |
| Working Capital | Rs146.90 Million | Rs103.25 Million | Rs60.13 Million |
Biofil Chemicals & Pharmaceuticals Limited - Advanced Valuation Insights
This section examines the relationship between Biofil Chemicals & Pharmaceuticals Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.74 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | 8.2% |
| Total Assets | Rs509.60 Million |
| Market Capitalization | $5.82 Million USD |
Valuation Analysis
Below Book Valuation: The market values Biofil Chemicals & Pharmaceuticals Limited's assets below their book value (0.01x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Biofil Chemicals & Pharmaceuticals Limited's assets grew by 8.2% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Biofil Chemicals & Pharmaceuticals Limited (2008–2025)
The table below shows the annual total assets of Biofil Chemicals & Pharmaceuticals Limited from 2008 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | Rs509.60 Million ≈ $5.51 Million |
+8.24% |
| 2024-03-31 | Rs470.83 Million ≈ $5.09 Million |
+49.92% |
| 2023-03-31 | Rs314.06 Million ≈ $3.40 Million |
+67.66% |
| 2022-03-31 | Rs187.32 Million ≈ $2.03 Million |
-43.64% |
| 2021-03-31 | Rs332.38 Million ≈ $3.59 Million |
-21.54% |
| 2020-03-31 | Rs423.65 Million ≈ $4.58 Million |
+74.97% |
| 2019-03-31 | Rs242.13 Million ≈ $2.62 Million |
+0.24% |
| 2018-03-31 | Rs241.55 Million ≈ $2.61 Million |
+10.60% |
| 2017-03-31 | Rs218.40 Million ≈ $2.36 Million |
-9.50% |
| 2016-03-31 | Rs241.32 Million ≈ $2.61 Million |
+75.42% |
| 2015-03-31 | Rs137.56 Million ≈ $1.49 Million |
-5.77% |
| 2014-03-31 | Rs145.99 Million ≈ $1.58 Million |
+8.19% |
| 2013-03-31 | Rs134.93 Million ≈ $1.46 Million |
-4.36% |
| 2012-03-31 | Rs141.09 Million ≈ $1.53 Million |
+35.91% |
| 2011-03-31 | Rs103.81 Million ≈ $1.12 Million |
+1.26% |
| 2010-03-31 | Rs102.52 Million ≈ $1.11 Million |
+22.09% |
| 2009-03-31 | Rs83.97 Million ≈ $908.16K |
-10.47% |
| 2008-03-31 | Rs93.79 Million ≈ $1.01 Million |
-- |
About Biofil Chemicals & Pharmaceuticals Limited
Biofil Chemicals and Pharmaceuticals Limited engages in manufacturing and trading of pharmaceuticals in India. It operates through Pharmaceutical and Chemical divisions. The company offers basic drugs and chemicals, such as sodium chloride, potassium chloride, sodium citrate, diethyl carbamazine citrate, ferrous sulphate, dried ferrous sulphate, ferrous fumerate, micro crystalline cellulose, and … Read more